First Eagle Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-253
Closed -$23K 301
2017
Q4
$23K Hold
253
﹤0.01% 306
2017
Q3
$524K Sell
253
-101
-29% -$7.75K ﹤0.01% 262
2017
Q2
$153K Sell
354
-56
-14% -$6.93K ﹤0.01% 265
2017
Q1
$2.43M Sell
410
-225
-35% -$32.1K 0.01% 192
2016
Q4
$185K Hold
635
﹤0.01% 255
2016
Q3
$817K Sell
635
-22
-3% -$2.19K ﹤0.01% 244
2016
Q2
$366K Sell
657
-351
-35% -$43.5K ﹤0.01% 277
2016
Q1
$2.61M Buy
1,008
+145
+17% +$29.4K 0.01% 195
2015
Q4
$7.26M Sell
863
-245
-22% -$79.7K 0.02% 169
2015
Q3
$4.6M Buy
1,108
+264
+31% +$116K 0.01% 175
2015
Q2
$2.85M Sell
844
-374
-31% -$159K 0.01% 193
2015
Q1
$10M Sell
1,218
-157
-11% -$60.8K 0.02% 163
2014
Q4
$11.3M Buy
1,375
+68
+5% +$20.2K 0.03% 160
2014
Q3
$6.01M Buy
1,307
+513
+65% +$113K 0.01% 180
2014
Q2
$5.51M Buy
794
+29
+4% +$5.9K 0.01% 186
2014
Q1
$4.82M Buy
765
+102
+15% +$31.2K 0.01% 165
2013
Q4
$5.06M Buy
663
+543
+453% +$96.6K 0.01% 169
2013
Q3
$135K Buy
+120
New +$19.3K ﹤0.01% 285

Other funds holding LUMO

First Eagle Investment Management's LUMO Position: Q1 2019 in Review

First Eagle Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2019, closing a stake of 6,667 shares — an estimated $91K sold.

First Eagle Investment Management first reported a position in LUMO in Q2 2013 and held it in 23 quarters. The position peaked at $78.3M in Q1 2015. 82 funds tracked by Wall St. Rank hold LUMO as of Q1 2019.

  • First Eagle Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • First Eagle Investment Management sold 6,667 Lumos Pharma, Inc. Common Stock shares in Q1 2019, an estimated $91K.
  • First Eagle Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
  • First Eagle Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $78.3M in Q1 2015.
  • 82 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2019.

Based on First Eagle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.